FrancesconiK.2006Urinary excretion of selenium
Jed Kaminetsky, Michael Werner, Greg Fontenot, Ronald D
DV2: DV2 infected HepG2 cells (MOI = 1), DV2+GSH: DV2 infected HepG2 cells with GSH treatment of 10 mM or 20 mM, DV2+BSO: DV2 infected HepG2 cells with BSO treatment of 0.2 mM or 1 mM
On the other hand, if a patient is fully reliant on the medication and experiences little to no hunger, those fluctuations may be less noticeable
Like the GLP-1 medications already on the market, eloralintide is a subcutaneous injection created to be taken once a week
It was approved for use as a weight-loss aid in the UK in 2023 by the Medicines and Healthcare products Regulatory Agency (MHRA)